These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 6789022
1. Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid). Grove J, Schechter PJ, Tell G, Koch-Weser J, Sjoerdsma A, Warter JM, Marescaux C, Rumbach L. Life Sci; 1981 May 21; 28(21):2431-9. PubMed ID: 6789022 [No Abstract] [Full Text] [Related]
2. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy. Menachem EB, Persson LI, Schechter PJ, Haegele KD, Huebert N, Hardenberg J, Dahlgren L, Mumford JP. Epilepsy Res; 1988 May 21; 2(2):96-101. PubMed ID: 3143561 [Abstract] [Full Text] [Related]
3. Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment. Pitkänen A, Matilainen R, Ruutiainen T, Riekkinen P. J Neurol Sci; 1988 Dec 21; 88(1-3):83-93. PubMed ID: 3225631 [Abstract] [Full Text] [Related]
7. Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA. Grove J, Tell G, Schechter PJ, Koch-Weser J, Warter JM, Marescaux C, Rumbach L. Lancet; 1980 Sep 20; 2(8195 pt 1):647. PubMed ID: 6107437 [No Abstract] [Full Text] [Related]
8. Cerebrospinal fluid GABA and seizure control with vigabatrin. Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkanen A. Br J Clin Pharmacol; 1989 Sep 20; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914 [Abstract] [Full Text] [Related]
9. [Concentration of free amino acids and homocarnosine dipeptide in the cerebrospinal fluid of children with hydrocephalus]. Bondarenko TI, Makletsova MG, Sukhomovskiĭ BI. Zh Nevropatol Psikhiatr Im S S Korsakova; 1983 Sep 20; 83(10):1484-8. PubMed ID: 6659780 [Abstract] [Full Text] [Related]
10. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea. Bonnet AM, Tell G, Schechter PJ, Grove J, Saint-Hilaire MH, De Smet Y, Agid Y. Mov Disord; 1987 Sep 20; 2(2):117-23. PubMed ID: 2973560 [Abstract] [Full Text] [Related]
11. Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism. Jaeken J, Casaer P, de Cock P, Corbeel L, Eeckels R, Eggermont E, Schechter PJ, Brucher JM. Neuropediatrics; 1984 Aug 20; 15(3):165-9. PubMed ID: 6148708 [Abstract] [Full Text] [Related]
12. Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling. Grove J, Schechter PJ, Hanke NF, de Smet Y, Agid Y, Tell G, Koch-Weser J. J Neurochem; 1982 Dec 20; 39(6):1618-22. PubMed ID: 7142991 [Abstract] [Full Text] [Related]
13. Vigabatrin for startle-disease with altered cerebrospinal-fluid free gamma-aminobutyric acid. Stephenson JB. Lancet; 1992 Aug 15; 340(8816):430-1. PubMed ID: 1353584 [No Abstract] [Full Text] [Related]
14. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration. Tell G, Böhlen P, Schechter PJ, Koch-Weser J, Agid Y, Bonnet AM, Coquillat G, Chazot G, Fischer C. Neurology; 1981 Feb 15; 31(2):207-11. PubMed ID: 6258106 [Abstract] [Full Text] [Related]
16. Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine. Grove J, Schechter PJ, Tell G, Rumbach L, Marescaux C, Warter JM, Koch-Weser J. J Neurochem; 1982 Oct 15; 39(4):1061-5. PubMed ID: 7119781 [Abstract] [Full Text] [Related]